Home / Compliance actions / 45718

FDA Warning Letter — BioReliance Corporation

Case 45718 — FEI 1122041

The FDA took a Warning Letter action against BioReliance Corporation on Jan 5, 2009 (Rockville, MD). The action was issued by CBER and concerns biologics products. This facility has 5 or more recent FDA inspections on record.

Action details

Facility
BioReliance Corporation
Date
Jan 5, 2009
Fiscal Year
2009
Product Type
Biologics
Center
CBER
Location
Rockville, MD (United States)

Facility

Recent inspections

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.